Literature DB >> 28488364

Comparison of the vaginal environment in rhesus and cynomolgus macaques pre- and post-lactobacillus colonization.

Gregory J Daggett1, Chunxia Zhao2, Fawn Connor-Stroud1, Patricia Oviedo-Moreno3, Hojin Moon4, Michael W Cho4, Thomas Moench5, Deborah J Anderson6, Francois Villinger7.   

Abstract

BACKGROUND: Rhesus and cynomologus macaques are valuable animal models for the study of human immunodeficiency virus (HIV) prevention strategies. However, for such studies focused on the vaginal route of infection, differences in vaginal environment may have deterministic impact on the outcome of such prevention, providing the rationale for this study.
METHODS: We tested the vaginal environment of rhesus and cynomolgus macaques longitudinally to characterize the normal microflora based on Nugent scores and pH. This evaluation was extended after colonization of the vaginal space with Lactobacilli in an effort to recreate NHP models representing the healthy human vaginal environment. RESULTS AND
CONCLUSION: Nugent scores and pH differed significantly between species, although data from both species were suggestive of stable bacterial vaginosis. Colonization with Lactobacilli was successful in both species leading to lower Nugent score and pH, although rhesus macaques appeared better able to sustain Lactobacillus spp over time.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  lactobacillus; macaque; microbiota; vagina

Mesh:

Year:  2017        PMID: 28488364      PMCID: PMC5597444          DOI: 10.1111/jmp.12264

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  32 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

Review 2.  Recent work on vaginal rings containing antiviral agents for HIV prevention.

Authors:  Patrick Spence; Anita Bhatia Garg; Cynthia Woodsong; Brid Devin; Zeda Rosenberg
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

3.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

4.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  The laboratory diagnosis of bacterial vaginosis.

Authors:  Deborah Money
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

6.  A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development.

Authors:  Rosa R Yu; Andrew T Cheng; Laurel A Lagenaur; Wenjun Huang; Deborah E Weiss; Jim Treece; Brigitte E Sanders-Beer; Dean H Hamer; Peter P Lee; Qiang Xu; Yang Liu
Journal:  J Med Primatol       Date:  2009-04       Impact factor: 0.667

7.  Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.

Authors:  L A Lagenaur; B E Sanders-Beer; B Brichacek; R Pal; X Liu; Y Liu; R Yu; D Venzon; P P Lee; D H Hamer
Journal:  Mucosal Immunol       Date:  2011-07-06       Impact factor: 7.313

8.  Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.

Authors:  Laurel A Lagenaur; Iwona Swedek; Peter P Lee; Thomas P Parks
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

9.  In captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiome.

Authors:  Gregory Spear; Kristina Rothaeulser; Linda Fritts; Patrick M Gillevet; Christopher J Miller
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Twice-daily application of HIV microbicides alter the vaginal microbiota.

Authors:  Jacques Ravel; Pawel Gajer; Li Fu; Christine K Mauck; Sara S K Koenig; Joyce Sakamoto; Alison A Motsinger-Reif; Gustavo F Doncel; Steven L Zeichner
Journal:  MBio       Date:  2012-12-18       Impact factor: 7.867

View more
  3 in total

1.  Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.

Authors:  David Tyssen; Ying-Ying Wang; Joshua A Hayward; Paul A Agius; Kevin DeLong; Muriel Aldunate; Jacques Ravel; Thomas R Moench; Richard A Cone; Gilda Tachedjian
Journal:  mSphere       Date:  2018-07-05       Impact factor: 4.389

Review 2.  Microbiome Studies in Non-human Primates.

Authors:  Jason M Brenchley; Alexandra M Ortiz
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-04       Impact factor: 5.071

3.  Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

Authors:  Philippe A Gallay; Udayan Chatterji; Aaron Kirchhoff; Angel Gandarilla; Richard B Pyles; Marc M Baum; John A Moss
Journal:  Open Virol J       Date:  2018-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.